Asset Allocation

As of March 31, 2026.
Type % Net
Cash 1.15%
Stock 97.65%
Bond 1.20%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 31.79%
Mid 21.97%
Small 46.24%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.99%    % Emerging Markets: 0.00%    % Unidentified Markets: 1.01%

Americas 86.14%
86.14%
United States 86.14%
0.00%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 12.85%
United Kingdom 0.00%
9.07%
Ireland 9.07%
0.00%
3.78%
Israel 3.78%
Greater Asia 0.00%
Japan 0.00%
0.00%
0.00%
0.00%
Unidentified Region 1.01%

Stock Sector Exposure

Cyclical
40.99%
Materials
3.82%
Consumer Discretionary
9.65%
Financials
25.41%
Real Estate
2.11%
Sensitive
41.38%
Communication Services
0.00%
Energy
7.94%
Industrials
18.64%
Information Technology
14.81%
Defensive
15.28%
Consumer Staples
5.92%
Health Care
9.36%
Utilities
0.00%
Not Classified
2.35%
Non Classified Equity
0.00%
Not Classified - Non Equity
2.35%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available